Dipna Pharmachem Limited
ListedSMEHealthcare · BSE
Incorporated in 2011, Dipna Pharmachem Limited is involved in the trading and distribution of a wide range of pharmaceutical raw materials, including APIs, excipients, and chemical formulation products, and began selling chemicals on a commission basis in 2022. Operating in Ahmedabad and nearby regions, the company offers a portfolio of 61 APIs and intermediates covering categories like cephalosporins, cardiovascular, antibacterial, quinolones, veterinary, antiviral, anti-inflammatory, neuropsychiatry, and steroid hormones. It supplies essential raw materials to pharmaceutical industries, a sector recognized as an essential service by the Government.
Price Band
₹38
Issue Size
₹15.21 Cr
Lot Size
3000 shares
GMP
—
Est. Listing
₹38
at current GMP
Subscribed
2.77x
overall
Open
25 Aug 2022
Close
30 Aug 2022
Allotment
5 Sep 2022
Refund
6 Sep 2022
Demat Credit
7 Sep 2022
Listing
8 Sep 2022
Last updated 12 days ago
Live Grey Market Premium
Dipna Pharmachem Limited GMP Today
Last updated: 19 Oct 2026
Current Premium
₹00.0%
Issue Price (Upper)
₹38
Band: ₹38
Estimated Listing Price
₹38
Upper price + GMP
Lot Size
3000 shares
Min investment ₹1,14,000
Estimated Profit / Lot
₹0
3000 × ₹0
Dipna Pharmachem Limited GMP Historical Trend
GMP History
Grey Market Premium trend
—
▲ 0 today
Updated 1 minute ago
Estimated Listing Price
| Date | GMP (₹) | GMP % | Est. Listing |
|---|---|---|---|
| 31 Oct 2026 | — | 0.0% | ₹38 |
| 30 Oct 2026 | — | 0.0% | ₹38 |
| 29 Oct 2026 | — | 0.0% | ₹38 |
GMP is unofficial market data. Not a guarantee of listing performance.
About Dipna Pharmachem Limited Public Issue & Market Profile
Dipna Pharmachem Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹15.21 Crores. The shares are offered at a price band of ₹38 to ₹38 per equity share on BSE. Currently, market analysts recommend evaluating the company's financial valuation, price-to-earnings (P/E) multiple, and peer comparison prior to submitting bids.
Public Issue & Pricing Context:
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Basis of Allotment & Listing Timeline:
Following the close of bidding on 2022-08-30, the basis of allotment is scheduled to be finalized on 2022-09-05. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Bigshare Services Private Limited) or the BSE allotment checking window.
Frequently Asked Questions
What is Dipna Pharmachem Limited IPO GMP today?
The latest grey market premium for Dipna Pharmachem Limited IPO is ₹0, which indicates an expected listing price of ₹38.
What does Kostak Rate and Sauda mean in IPO GMP?
Kostak rate is the profit amount an investor earns by selling their entire IPO application in the grey market before allotment is finalized.
Is Grey Market Premium officially recognized?
No. GMP is an unofficial indicator discovered between dealers outside of SEBI-regulated exchanges. Actual listing price is determined by demand-supply discovery on NSE/BSE during the pre-open auction.